Advertisement
Screener

Cadre Holdings, Inc. (CDRE) Overview

Cadre Holdings, Inc. (CDRE) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 0.26; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 0.05; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 0.27; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 0.30; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$24.25$27.86$32.00$36.76$42.22$48.502025-11-062026-11-06$16.25$20.43$25.68$32.29$40.60$51.052021-11-082026-11-06$14.53$18.68$24.01$30.88$39.70$51.052021-11-042026-11-06$14.53$18.68$24.01$30.88$39.70$51.052021-11-042026-11-06$14.53$18.68$24.01$30.88$39.70$51.052021-11-042026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$32.70
Previous close
$25.53
Change
$7.16
Change (%)
28.07%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

CDRE
-36.91%
S&P 500
(m)

1 year

CDRE
-28.72%
S&P 500
(m)

3 years

CDRE
-1.01%
S&P 500
(m)

5 years

CDRE
(m)
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 0.26

-0.030.100.230.350.4831 Mar 2025: estimate (m); actual 0.2331 Mar 2025(m)30 Jun 2025: estimate (m); actual 0.3030 Jun 2025(m)30 Sept 2025: estimate (m); actual 0.2730 Sept 2025(m)31 Mar 2026: estimate (m); actual 0.0531 Mar 2026(m)30 Jun 2026: estimate (m); actual 0.2630 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)0.26(m)(m)
1 Jan 202631 Mar 2026(m)0.05(m)(m)
1 Jul 202530 Sept 2025(m)0.27(m)(m)
1 Apr 202530 Jun 2025(m)0.30(m)(m)
1 Jan 202531 Mar 2025(m)0.23(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 1.02

0.080.360.640.921.2031 Dec 2021: estimate (m); actual 0.4431 Dec 2021(m)31 Dec 2022: estimate (m); actual 0.1631 Dec 2022(m)31 Dec 2023: estimate (m); actual 1.0231 Dec 2023(m)31 Dec 2024: estimate (m); actual 0.9031 Dec 2024(m)31 Dec 2025: estimate (m); actual 1.0231 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)1.02(m)(m)
1 Jan 202431 Dec 2024(m)0.90(m)(m)
1 Jan 202331 Dec 2023(m)1.02(m)(m)
1 Jan 202231 Dec 2022(m)0.16(m)(m)
1 Jan 202131 Dec 2021(m)0.44(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 207.13M ■ Earnings 11.41M — Profit margin 5.51%

-24.86M0.3%60.76M2.9%146.37M5.4%231.98M8.0%30 Sept 2025: revenue 155.87M; earnings 10.94M; profit margin 7.02%30 Sept 202531 Dec 2025: revenue 167.22M*; earnings 11.74M*; profit margin 7.02%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 155.43M; earnings 1.98M; profit margin 1.27%31 Mar 202630 Jun 2026: revenue 207.13M; earnings 11.41M; profit margin 5.51%30 Jun 2026

31 Dec 2025 ■ Revenue 610.31M ■ Earnings 44.14M — Profit margin 7.23%

-73.24M0.3%179.02M3.2%431.28M6.1%683.54M9.0%31 Dec 2022: revenue 457.84M; earnings 5.82M; profit margin 1.27%31 Dec 202231 Dec 2023: revenue 482.53M; earnings 38.64M; profit margin 8.01%31 Dec 202331 Dec 2024: revenue 567.56M; earnings 36.13M; profit margin 6.37%31 Dec 202431 Dec 2025: revenue 610.31M; earnings 44.14M; profit margin 7.23%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$32.70(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$32.70High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning CDRE

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$36.06M
Profit margin
5.26%
Return on assets · 12 month
4.21%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
489.47K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-5.02%*
Total return · month
-16.95%*
Total return · quarter
-6.38%*
Total return · half year
-14.22%*
Total return · year to date
-36.91%*
Total return · 1 year
-28.72%*
Total return · 3 years
-1.01%*
Total return · 5 years
(m)
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$685.65M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
107.94%*
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Cadre Holdings, Inc. Overview

View more →

(m)

(m)

SEC CIK
1860543
Industry (SIC)
3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
Country of operation
United States
Business address
13386 INTERNATIONAL PKWY, JACKSONVILLE, Florida, 32218, United States
Fiscal year end
1231
Phone
(904) 741-5400

Similar stocks

Stock NameCountryMarket CapPE Ratio
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85